185.96 USD
-1.02 (-0.55%)
185.96 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to AXSM. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 207.38. This target is 11.52% above the current price.
- AXSM was analyzed by 26 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about AXSM.
- In the previous month the buy percentage consensus was at a similar level.
- AXSM was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-08 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2026-01-06 | UBS | Maintains | Buy -> Buy |
| 2026-01-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-12-31 | Needham | Maintains | Buy -> Buy |
| 2025-11-06 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-04 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-04 | Needham | Reiterate | Buy -> Buy |
| 2025-11-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-04 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-04 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-20 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-01 | B. Riley Securities | Initiate | Buy |
| 2025-08-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-05 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-04 | Needham | Reiterate | Buy -> Buy |
| 2025-06-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-09 | Needham | Maintains | Buy -> Buy |
| 2025-06-03 | Oppenheimer | Initiate | Outperform |
| 2025-05-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-06 | Baird | Maintains | Outperform -> Outperform |
| 2025-04-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-07 | Jefferies | Initiate | Buy |
AXSOME THERAPEUTICS INC / AXSM FAQ
Can you provide the average price target for AXSOME THERAPEUTICS INC stock?
26 analysts have analysed AXSM and the average price target is 207.38 USD. This implies a price increase of 11.52% is expected in the next year compared to the current price of 185.96.
Can you provide the consensus rating for AXSOME THERAPEUTICS INC stock?
The consensus rating for AXSOME THERAPEUTICS INC (AXSM) is 86.1538 / 100 . This indicates that analysts generally have a positive outlook on the stock.